Shares of SenesTech SNES fell 0.7% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 83.05% over the past year to ($0.10), which beat the estimate of ($0.15).
Revenue of $160,000 rose by 125.35% year over year, which beat the estimate of $90,000.
Outlook
SenesTech hasn't issued any earnings guidance for the time being.
SenesTech hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: Aug 12, 2021
Time: 05:00 PM
ET Webcast URL: https://senestech.investorroom.com/events
Recent Stock Performance
52-week high: $3.20
Company's 52-week low was at $1.30
Price action over last quarter: Up 7.75%
Company Profile
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.